Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Diabetes drug may be useful in treatment of X-linked adrenoleukodystrophy

June 25, 2013

Boehringer Ingelheim presents novel agents for diabetes and obesity

June 21, 2013

Application seeking approval of tofogliflozin submitted in Japan

June 21, 2013

Phase I/II results presented for the long-acting rhGH in children

June 21, 2013

FDA advisory committee sets date to review Amarin's sNDA for Vascepa

June 20, 2013

Target enrollment reached in phase II trial of CCX-140 in diabetic nephropathy

June 20, 2013

Raptor launches Procysbi in the U.S.

June 20, 2013

DARA BioSciences grants DB-959 worldwide rights to T3D Therapeutics

June 20, 2013

New EP2 receptor antagonists patented by Bayer

June 19, 2013

Isis Pharmaceuticals presents phase I data for ISIS-PTP-1BRx

June 19, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...